Introducing the ADEXUSDx COVID-19 Test

Introducing the ADEXUSDx COVID-19 Test

At NOWDiagnostics, we’re always looking for ways to respond to community needs. Our new, rapid ADEXUSDx COVID-19 serology antibody test will be essential to America’s recovery from COVID-19, as we believe it can assist with vaccine development and contact tracing.

Interested in learning more? You can read the full article and watch the video here.

NOWDiagnostics, Inc., based in Springdale, Arkansas, is a leader in innovative diagnostics testing. Its ADEXUSDx® product line features a lab at your fingertip, using a single drop of blood to test for a variety of common conditions, illnesses, and diseases, with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics products have the potential to decrease the waiting period to determine test results by days. For more information about NOWDiagnostics, visit www.nowdx.com. For more information about the ADEXUSDx® COVID-19 Test, including its intended use, features, benefits and limitations, and directions for use, visit www.c19development.com. The ADEXUSDx® COVID-19 Test will be distributed by C19 Development, LLC, a wholly owned subsidiary of NOWDiagnostics. Laboratories may contact www.c19development.com/order to place an order.